Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
信熹资本 (Sincere VC) was founded in 2015 and is headquartered in Shanghai, China. The firm focuses on identifying long-term value investment opportunities that arise from China's economic transformation and upgrading process. Sincere VC specializes in hard technology investments, particularly in intelligent technology and life sciences, which are critical sectors in the current economic landscape.
As of now, Sincere VC has built a notable portfolio that includes several high-profile companies in the hard technology sector. The firm operates with a team composed primarily of professionals with advanced degrees, ensuring a high level of expertise in their investment decisions. Although specific metrics such as assets under management (AUM) and fund sizes are not disclosed, the firm is recognized for its deep research-driven underwriting process and strong affiliations with government and academic institutions.
Notable milestones include the co-initiation of the Shanghai North Bund Financial Institute (NBFI), which conducts research in the hard-tech industry, and hosting the North Bund Hard-tech Conference, which fosters collaboration and innovation in the sector.
Sincere VC invests primarily in two sectors: intelligent technology and life sciences. The firm emphasizes long-term investments in high-tech products and technologies that possess significant barriers to entry. This focus aligns with their investment philosophy of supporting companies that demonstrate genuine technological innovation and contribute to social value through advanced technologies.
In the intelligent technology sector, Sincere VC targets investments in areas such as IoT, semiconductors, and AI-adjacent hardware. In life sciences, the firm looks for innovative drugs and medical devices that can significantly impact healthcare. Sincere VC's investment strategy is characterized by a concentrated, conviction-driven approach, often described as a
Sincere VC's notable portfolio includes several prominent companies: 睿创微纳 (688002.SH), a leader in the infrared chip industry; CPIC (301526.SZ), a top global player in fiberglass new materials; 君实生物 (688180.SH, 1877.HK), the first approved PD-1 cancer drug in China; 兆芯集成电路, a leading domestic CPU manufacturer; 禾元生物, a pioneer in plant-derived recombinant human serum albumin; 真迈生物, the first company in China to develop a proprietary single-molecule gene sequencer; and 浪潮云, a leading provider of government cloud services in China.
When pitching to Sincere VC, include detailed information about your technology's barriers to entry and its potential social impact. A clear alignment with their focus on hard technology is essential.
What are Sincere VC's investment criteria?
Sincere VC focuses on hard technology investments in intelligent technology and life sciences, seeking companies with significant barriers to entry and a commitment to social value.
How does Sincere VC support its portfolio companies?
The firm provides strategic support and guidance, leveraging its strong network of government and academic affiliations to help companies navigate the complexities of the high-tech landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.